AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Optic Neuritis

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site๐Ÿ“ Marseille Assistance Publique Hopitaux De Marseille ยท Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD NCT06780709NA1 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Wellness Program and Behavioral Counseling Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) NCT05145361EARLY Phase 14 sites๐Ÿ“ Beijing๐Ÿ“ Taiyuan๐Ÿ“ Xiโ€™an Shanghai Pharmaceuticals Holding Co., Ltd ยท Tests: B001 injection, Placebo A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) NCT06413654Phase 2, Phase 351 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Shanghai Jiaolian Drug Research and Development Co., Ltd ยท Tests: B001, Placebo Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study NCT07410039Phase 41 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Eculizumab+IVMP, IVIG+IVMP, IVMP VIsual Pathways Model in Neuro-inflammatory Disorders NCT05487989n/a1 site๐Ÿ“ Lille University Hospital, Lille ยท Tests: Clinical examen Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) NCT02521311Phase 21 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Clemastine, Placebo Ofatumumab in AQP4-IgG Seropositive NMOSD NCT05504694Phase 1, Phase 21 site๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Ofatumumab Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site๐Ÿ“ Jerusalem Polina Stepensky ยท Tests: HBI0101 CART Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis NCT03401879NA1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Dynamic Vessel Analyzer (DVA), Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Optical coherence tomographโ€ฆ Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE) NCT04106830n/a1 site๐Ÿ“ Beijing Beijing Tiantan Hospital ยท Tests: Intravenous steroid HANDLE-a Real World Study on Satralizumab in NMOSD NCT06829524n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: Satralizumab Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) NCT07557420Phase 310 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Chengdu Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab Study of Ultomirisยฎ (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites๐Ÿ“ Boston๐Ÿ“ Melbourne๐Ÿ“ Paris Alexion Pharmaceuticals, Inc. ยท Tests: Ultomiris MS-ResearchBiomarkerS NCT05204459n/a1 site๐Ÿ“ Los Angeles Cedars-Sinai Medical Center A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD NCT07762872n/a1 site๐Ÿ“ Beijing Junwei Hao, MD ยท Tests: Satralizumab Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies NCT05966467n/a33 sites๐Ÿ“ Washington D.C.๐Ÿ“ Boston๐Ÿ“ Chapel Hill Alexion Pharmaceuticals, Inc. Biomarkers in Autoimmune Disease of Nervous System NCT06502015n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: biomaker levels Cohort Study on Neuroimmune Diseases in the Reproductive Age NCT07653984n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNAยฎ During Pregnancy NCT05909761n/a1 site๐Ÿ“ Aurora Amgen ยท Tests: UPLIZNA Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder NCT07420296Phase 31 site๐Ÿ“ Tianjin Tianjin Medical University General Hospital ยท Tests: Eculizumab administration, High-dose corticosteroid pulse therapy, Plasma exchange (PE) Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders NCT05982925n/a1 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases NCT07022197Phase 1, Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University General Hospital ยท Tests: BAFF-R CART Edaravone in the Treatment of Optic Neuritis NCT05540262NA1 site๐Ÿ“ Nanning First Affiliated Hospital of Guangxi Medical University ยท Tests: Edaravone Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD) NCT07377305NA1 site๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: 10Hz tTIS (2-4mA) Intervention Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder NCT05549258Phase 219 sites๐Ÿ“ La Jolla๐Ÿ“ Loma Linda๐Ÿ“ Boston Amgen ยท Tests: Inebilizumab Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD NCT05566769NA22 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ Tampa Ad scientiam ยท Tests: NMOSDCopilot smartphone application Stem Cell Ophthalmology Treatment Study II NCT03011541NA4 sites๐Ÿ“ Westport๐Ÿ“ Coral Springs๐Ÿ“ Vienna MD Stem Cells ยท Tests: Arm 1 RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry NCT04448938n/a1 site๐Ÿ“ Paris Fondation Ophtalmologique Adolphe de Rothschild ยท Tests: MRI, visual acuity Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. NCT07526493Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Universal CD19 CAR-ฮณฮดT Cell Injection, Cyclophosphamide, Fludarabine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy